An Amniotic Membrane Injection Comparing Two Doses (1 mL and 2mL Injection) in the Treatment of Osteoarthritis of the Knee

NCT04201743 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Resources limited secondary to COVID-19 pandemic.

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Acellular amniotic membrane derived allograft injection (NuDYN)

Sponsor

Illinois Center for Orthopaedic Research and Education